MedPath

Midazolam Hydrochloride

MIDAZOLAM HYDROCHLORIDE SYRUP CIV For oral use

Approved
Approval ID

2d62891b-06e1-4c21-bb7d-73b6aa19eb22

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 5, 2023

Manufacturers
FDA

Major Pharmaceuticals

DUNS: 191427277

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Midazolam Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0904-7113
Application NumberANDA075873
Product Classification
M
Marketing Category
C73584
G
Generic Name
Midazolam Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateOctober 28, 2021
FDA Product Classification

INGREDIENTS (11)

MIDAZOLAM HYDROCHLORIDEActive
Quantity: 2 mg in 1 mL
Code: W7TTW573JJ
Classification: ACTIM
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0L
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Midazolam Hydrochloride - FDA Drug Approval Details